This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sichuan University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Inventor Xin Ma
Introduction
Xin Ma is a notable inventor based in Chengdu, China. He has made significant contributions to the field of medical treatments, particularly in addressing developmental dysplasia of the hip. His innovative approach has led to the development of a unique pharmaceutical composition aimed at improving patient outcomes.
Latest Patents
Xin Ma holds a patent for "Methods for treating developmental dysplasia of the hip." This patent outlines a method that includes administering a therapeutically effective amount of a pharmaceutical composition to a subject suffering from this condition. The composition features a substance capable of inhibiting the expression of Midkine (MDK), specifically utilizing a Midkine inhibitor (IMDK). This innovative treatment has the potential to enhance the quality of life for individuals affected by this condition.
Career Highlights
Xin Ma is affiliated with Sichuan University, where he conducts research and develops his innovative ideas. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients. With a focus on practical applications, he has successfully translated his research into patentable inventions.
Collaborations
Xin Ma collaborates with esteemed colleagues, including Weili Fu and Runze Yang. These partnerships foster a dynamic research environment that encourages the exchange of ideas and expertise, ultimately leading to more effective solutions in the medical field.
Conclusion
Xin Ma's contributions to the treatment of developmental dysplasia of the hip exemplify the impact of innovation in medicine. His work not only highlights the importance of research and collaboration but also underscores the potential for patents to drive advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile